Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brinzolamide Adjunctive to Travoprost in Chronic Angle-Closure Glaucoma
NCT00758342Phase 4Terminated
- Sponsor
- Alcon Inc.
- Start
- May 2006
- Primary completion
- Mar 2008
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of brinzolamide in chronic angle-closure glaucoma (CACG), sponsored by Alcon Inc.. Started May 2006; status: terminated.
02
Drugs
brinzolamide
03
Conditions
chronic angle-closure glaucoma (CACG)
Beyond the preview
Go deeper on NCT00758342.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00758342.